F-Prime Capital — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
BiotechSouth San Francisco, US
Raymond Stevens(Director)Ramy Farid(Director)Jessica Lifton(Director)Ting Xie(Director)Daniel Auerbach(Director)Cuiping Gu(Director)
Board seatRobert Weisskoff· per SEC Form D · $7M raise · filed Jan 2022
Argyle provides a verification platform that automates the collection and verification of income, employment, and asset data using consumer-permissioned, real-time data from payroll, banking, and document sources.
Data & InfrastructureFintechNew York, US
Samuel Fishman(Executive Officer, Director, Promoter)Shmulik Fishman(Founder)inDaniel Yanisse(Director)Christopher Hansen(Executive Officer, Director)
Co-investorsRackhouse Venture Management LpSignalFireBain Capital VenturesSocially FinancedSocii Capital
ConnexPay provides a payment platform that lets businesses accept customer payments and fund immediate supplier payments via virtual cards from the same transaction, closing the cash flow gap.
FintechSaaSTravel & HospitalityBonita Springs, US
Robert Kaufman(Chief Executive Officer and member of the Board of Managers)inBob Kaufman(Founder)
BoardMark Buffington(Member of the Board of Managers)inJacob Eisen(Member of the Board of Managers)Pamela Joseph(Member of the Board of Managers)Barbara Polsky(Member of the Board of Managers)
Co-investorsBIP VenturesFTV CapitalTamiami AngelBIP Capital
Proximie provides a cloud-based operating system for connected operating rooms, giving medtech companies and hospitals real-time OR connectivity, structured surgical data, and AI-driven insights.
AI & Machine LearningDigital HealthMedical DevicesSaaSAltrincham
Nadine Haram(Director)Nadine Hachach-Haram(Founder)Jonathan Lim(Director)inScott Huennekens(Director)
BoardMohammed Shahzad Ahmed Malik(Director)
Co-investorsAdvent Life SciencesCapria VenturesCedar Mundi VenturesCOTU VenturesDraper AssociatesQuesta Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.